FDA NDC Directory · JSON-LD · Markdown
NDC 57237-159 · HUMAN PRESCRIPTION DRUG · TABLET
| Labeler / Manufacturer | Rising Pharma Holdings, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA203820 |
| Dosage form / route | TABLET · ORAL |
| Active ingredients | REPAGLINIDE (2 mg/1) |
| Marketing started | 20140122 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).